Justin A. Renz
CFO & TreasurerMr. Justin A. Renz, CPA, MST, MBA, is Chief Financial Officer and Treasurer of Zevra Therapeutics, Inc. from March 9, 2026. He had been Chief Financial Officer of Ardelyx, Inc. since June 2020 until November 04, 2025 and served as Chief Accounting Officer since June 9, 2020 until March 10, 2022 and served as its Chief Operation Officers since January 2023 until November 04, 2025. He joined Ardelyx, Inc in June 8, 2020. Mr. Renz served as Treasurer at Ardelyx, Inc. Mr. Renz served as Principal Financial Officer at Ardelyx, Inc. since June 9, 2020. Mr. Renz was Chief Financial Officer and President of Correvio Pharma Corp. since May 16, 2017 until May 27, 2020 and since January 01, 2019 until May 27, 2020 respectively. He served as an Advisor of Karyopharm Therapeutics Inc., since April 3, 2017 until January 31, 2018. Mr. Renz served as the Chief Financial Officer, Executive Vice President and Treasurer at Karyopharm Therapeutics Inc. since August 18, 2014 until April 3, 2017. Mr. Renz served as the Chief Financial Officer from September 2006 to July 2014 at Zalicus Inc. (formerly CombinatoRx, Incorporated) since July 2009 and as its Treasurer since September 2006. Mr. Renz also served as Principal Accounting Officer and Executive Vice President of Zalicus Inc. and its Secretary since March 2014. He served as Vice President of Finance at Zalicus Inc. from September 2006 to July 2009 and served as its Senior Vice President since July 2009 and also as its Chief Financial Officer from September 2006 to July 2014. He joined Zalicus Inc. in September 2006. He oversaw multiple rounds of equity and debt financing and led the Zalicus Inc.'s asset monetization strategy and two reverse mergers. He served as the Chief Financial Officer, Executive Vice President, Treasurer and Secretary at EPIRUS Biopharmaceuticals, Inc. until July 15, 2014. From August 2005 to September 2006, Mr. Renz served as Director of Accounting and Financial Operations at EMD Serono. He served in Senior Finance and Accounting roles at Serono, Inc. From 2002 to 2005, he served as Senior Director of Global Accounting and Finance at Coley Pharmaceutical Group, Inc. He served as Senior Finance Director of Coley Pharmaceutical Group, Inc. and also served in Financial and Accounting positions at ArQule, Inc., Millipore Corporation and Arthur Andersen LLP. He has experience in the biopharmaceutical industry. Mr. Renz holds a B.A. in Economics/Accounting from the College of the Holy Cross, a Masters in the Science of Taxation from Northeastern University and an MBA from Suffolk University. He is a Certified Public Accountant in Massachusetts.
Positions
- Company NameZevra Therapeutics, Inc.Stock CodeZVRAPositionCFO & TreasurerColleagues
- NFNeil F. McFarlanePresident, CEO & Director
- TATamara A. FavoritoIndependent Chair
- RWRahsaan W. ThompsonChief Legal Officer, Secretary & Compliance Officer
- NLNichol L. OchsnerVice President of Investor Relations & Corporate Communications
- APAlison PetersChief People Officer
- BBBarney BishopChairman of Scientific and Medical Advisory Board
- JAJeffrey A. GudinCo-Chair of Physician Advisory Council
- SNSrinivas NalamachuCo-Chair of Physician Advisory Council
